Measured Versus Self-Reported Compliance With Doxycycline Therapy for Chlamydia-Associated Syndromes
Article Abstract:
Many patients may overestimate their compliance with medication. In a study of 221 people treated with doxycycline for a sexually transmitted disease called chlamydia, all were given the medication in a bottle with a Medication Event Monitoring System (MEMS) cap. These caps record each time the bottle is opened. Although 90% reported taking their medication as directed, only 33 patients actually did so according to data obtained from the MEMS cap. Even with this low level of compliance, however, only 6% of follow-up urine cultures were positive for chlamydia.
Publication Name: Sexually Transmitted Diseases
Subject: Health
ISSN: 0148-5717
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
Treating chlamydial infection: compliance versus cost
Article Abstract:
Research and experience suggest that, even though more costly, supervised single-dose azithromycin treatment should be the routine treatment for patients with chlamydia infections. Multiple-dose doxycycline treatment taken at home can be reserved for patients trusted to complete the medication cycle. Study results have been mixed on the effectiveness of each treatment strategy, possibly explained by study design flaws. Short-term medication costs may, however, far outweigh the long-term health care costs of incompletely treated chlamydia infections.
Publication Name: Sexually Transmitted Diseases
Subject: Health
ISSN: 0148-5717
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Compliance with doxycycline therapy in sexually transmitted diseases clinics
Article Abstract:
Many patients given doxycycline therapy for chlamydia may not take their medication as specified. Specialized caps were used on bottles of doxycycline tablets to monitor how frequently 179 patients took their medication. Only 25% of the patients took their medication exactly as specified with 51% taking it fairly regularly. Twenty-four percent of the patients either delayed treatment for at least two days after being given the medication or regularly skipped medication for entire days.
Publication Name: Sexually Transmitted Diseases
Subject: Health
ISSN: 0148-5717
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Expanding the use of thrombolytic therapy for acute myocardial infarction. Treatment-seeking behavior among those with signs and symptoms of acute myocardial infarction
- Abstracts: Assessing and enhancing compliance with antiretroviral therapy. HIV and HAART in 1997
- Abstracts: Turning outcomes into plans. Planning for learning. Lesson-planning
- Abstracts: Evaluation of postdoctoral physician-scientist training programs in obstetrics and gynecology. Is the academic physician-scientist an oxymoron in contemporary obstetrics and gynecology?
- Abstracts: NSCA conference report: 13 new strength-training strategies. The bench rules